for the Period Ended 30 November 2023
Directors report | |
Profit and loss | |
Balance sheet | |
Additional notes | |
Balance sheet notes |
Directors' report period ended
The directors present their report with the financial statements of the company for the period ended 30 November 2023
Principal activities of the company
Political and charitable donations
Company policy on disabled employees
Additional information
Review of business and future developments The level of sales of the Company and its investments during the year were consistent with forecasts and an improvement on the prior year, despite supply chain dislocation impacting customer lead times. The financial position at 30 November 2023 is slightly behind expectations. Opportunities for developing the global position of Seal laboratory equipment continue to be explored. Further discussion of the business review and future developments, in the context of the Porvair group as a whole, including the Company, is provided in the Chairman’s statement, Chief Executive’s report and the Finance Director’s review in the Porvair plc 2023 annual report and financial statements, which does not form part of this report.
Directors
The directors shown below have held office during the whole of the period from
1 December 2022
to
30 November 2023
Secretary
The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006
This report was approved by the board of directors on
And signed on behalf of the board by:
Name:
Status: Secretary
for the Period Ended
2023 | 2022 | |
---|---|---|
|
£ |
£ |
Turnover: |
|
|
Cost of sales: |
(
|
(
|
Gross profit(or loss): |
|
|
Distribution costs: |
(
|
(
|
Administrative expenses: |
(
|
(
|
Other operating income: |
|
|
Operating profit(or loss): |
( |
( |
Interest receivable and similar income: |
|
|
Interest payable and similar charges: |
|
|
Profit(or loss) before tax: |
( |
( |
Tax: |
|
(
|
Profit(or loss) for the financial year: |
( |
( |
As at
Notes | 2023 | 2022 | |
---|---|---|---|
|
£ |
£ |
|
Called up share capital not paid: |
|
|
|
Fixed assets | |||
Intangible assets: | 3 |
|
|
Tangible assets: | 4 |
|
|
Investments: | 5 |
|
|
Total fixed assets: |
|
|
|
Current assets | |||
Stocks: | 6 |
|
|
Debtors: | 7 |
|
|
Cash at bank and in hand: |
|
|
|
Investments: |
|
|
|
Total current assets: |
|
|
|
Prepayments and accrued income: |
|
|
|
Creditors: amounts falling due within one year: | 8 |
(
|
(
|
Net current assets (liabilities): |
|
|
|
Total assets less current liabilities: |
|
|
|
Creditors: amounts falling due after more than one year: |
|
|
|
Provision for liabilities: |
|
|
|
Accruals and deferred income: |
|
|
|
Total net assets (liabilities): |
|
|
|
Capital and reserves | |||
Called up share capital: |
|
|
|
Share premium account: |
|
|
|
Other reserves: |
|
|
|
Profit and loss account: |
|
|
|
Total Shareholders' funds: |
|
|
The notes form part of these financial statements
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 30 November 2023
Basis of measurement and preparation
Turnover policy
Tangible fixed assets depreciation policy
Intangible fixed assets amortisation policy
Other accounting policies
for the Period Ended 30 November 2023
2023 | 2022 | |
---|---|---|
Average number of employees during the period |
|
|
for the Period Ended 30 November 2023
Goodwill | Other | Total | |
---|---|---|---|
Cost | £ | £ | £ |
At 1 December 2022 |
|
|
|
Additions |
|
|
|
Disposals |
|
|
|
Revaluations |
|
|
|
Transfers |
|
|
|
At 30 November 2023 |
|
|
|
Amortisation | |||
At 1 December 2022 |
|
|
|
Charge for year |
|
|
|
On disposals |
|
|
|
Other adjustments |
|
|
|
At 30 November 2023 |
|
|
|
Net book value | |||
At 30 November 2023 |
|
|
|
At 30 November 2022 |
|
|
|
for the Period Ended 30 November 2023
Land & buildings | Plant & machinery | Fixtures & fittings | Office equipment | Motor vehicles | Total | |
---|---|---|---|---|---|---|
Cost | £ | £ | £ | £ | £ | £ |
At 1 December 2022 |
|
|
|
|||
Additions |
|
|
||||
Disposals |
(
|
(
|
||||
Revaluations | ||||||
Transfers | ||||||
At 30 November 2023 |
|
|
|
|||
Depreciation | ||||||
At 1 December 2022 |
|
|
||||
Charge for year |
|
|
||||
On disposals |
(
|
(
|
||||
Other adjustments | ||||||
At 30 November 2023 |
|
|
||||
Net book value | ||||||
At 30 November 2023 |
|
|
|
|||
At 30 November 2022 |
|
|
|
for the Period Ended 30 November 2023
10 Investments Shares in group undertakings £’000 Cost at 30 November 2022 and 30 November 2023 2,703 Provision for impairment As at 30 November 2022 495 Impairment in the year - At 30 November 2023 495 Net book value at 30 November 2023 2,208 Net book value at 30 November 2022 2,208 The Directors have considered the carrying value of investments and have concluded that it is supported by their underlying net assets. For the year ended 30 November 2023, there was no impairment of the investments and as at 30 November 2023 no further payments are due to be paid. The Company has the following subsidiary undertakings: Subsidiary undertakings Principal activity Country of incorporation % ordinary shares held and voting rights Pulse Instrumentation GmbH Rohasys B.V. Seal Analytical GmbH Sale of water analysis consumables Manufacture and sale of robotic sample handling systems Manufacture and sale of water analysis equipment and related consumables Germany Netherlands Germany 100% 100% 100%
for the Period Ended 30 November 2023
2023 | 2022 | |
---|---|---|
£ | £ | |
Stocks |
|
|
Total |
|
|
for the Period Ended 30 November 2023
2023 | 2022 | |
---|---|---|
£ | £ | |
Trade debtors |
|
|
Other debtors |
|
|
Total |
|
|
for the Period Ended 30 November 2023
2023 | 2022 | |
---|---|---|
£ | £ | |
Trade creditors |
|
|
Taxation and social security |
|
|
Accruals and deferred income |
|
|
Total |
|
|